Aditi M. Mehta - Publications

Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 25, 2024

Cellular EMT-status governs contact guidance in an electrospun TACS-mimicking in vitro model.

Journal: Materials today. Bio

Published: October 17, 2024

Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.

Journal: Journal of medical economics

Published: May 10, 2024

Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol.

Journal: Blood advances

Published: October 24, 2023

Analytical techniques for the characterization of nanoparticles for mRNA delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 26, 2023

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial.

Journal: The Lancet. Oncology

Published: August 03, 2023

Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score.

Journal: Discover oncology

Published: July 16, 2023

The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: April 25, 2023

An In Vitro Approach to Model EMT in Breast Cancer.

Journal: International journal of molecular sciences

Published: March 07, 2023

Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 14, 2022

Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer.

Journal: Theranostics

Published: October 03, 2022

Feasibility of Cognitive Training to Promote Recovery in Cancer-Related Cognitive Impairment in Adolescent and Young Adult Patients.

Journal: Journal of adolescent and young adult oncology

Published: October 21, 2021